We are live on ! Find out more
ALT icon

Altimmune

28 hedge funds and large institutions have $2.44M invested in Altimmune in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $2.18M → $2.44M (+$252K)

1.18% more ownership

Funds ownership: 7.27%8.46% (+1.2%)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

7% less funds holding

Funds holding: 3028 (-2)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

Holders
28
Holders Change
-2
Holders Change %
-6.67%
% of All Funds
0.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
7
Reduced
7
Closed
8
Calls
$58K
Puts
Net Calls
+$58K
Net Calls Change
+$74K
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.01M
Renaissance Technologies
2
Renaissance Technologies
New York
$328K +$240K +129,736 +297%
WG
3
Winton Group
United Kingdom
$185K +$82.5K +44,696 +84%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$162K
Bank of New York Mellon
5
Bank of New York Mellon
New York
$144K
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$102K -$22.3K -12,059 -18%
SM
7
Sabby Management
Florida
$85K +$5.72K +3,097 +7%
BCM
8
Bridgeway Capital Management
Texas
$68K +$66.7K +36,100 New
BlackRock
9
BlackRock
New York
$64K -$654 -354 -1%
Bank of America
10
Bank of America
North Carolina
$47K -$63 -34 -0.1%
Citadel Advisors
11
Citadel Advisors
Florida
$46K +$13.5K +7,295 +43%
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$34K -$4.75K -2,572 -13%
VF
13
Virtu Financial
New York
$29K -$28K -15,186 -50%
Allianz Asset Management
14
Allianz Asset Management
Germany
$29K +$28.1K +15,200 New
CG
15
Caprock Group
Idaho
$29K +$28.1K +15,200 New
Northern Trust
16
Northern Trust
Illinois
$25K -$5.29K -2,863 -18%
AG
17
Advisor Group
Arizona
$16K +$2.03K +1,100 +15%
Morgan Stanley
18
Morgan Stanley
New York
$11K -$286 -155 -3%
Carson Wealth (CWM LLC)
19
Carson Wealth (CWM LLC)
Nebraska
$10K
UBS Group
20
UBS Group
Switzerland
$6K +$4.99K +2,700 +626%
PAM
21
Panagora Asset Management
Massachusetts
$2K +$1.86K +1,010 New
APA
22
American Portfolios Advisors
New York
$1.89K
Federated Hermes
23
Federated Hermes
Pennsylvania
$1K +$412 +223 +152%
OGC
24
One68 Global Capital
New York
$1K +$25.4K +13,756 New
ARTA
25
A.R.T. Advisors
New York
-$55K -28,324 Closed

ALT Hedge Fund Activity: Q4 2019 in Review

28 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q4 2019, worth a combined $2.44M — up 12% from $2.18M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ALT and 6 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 7 added.

The largest buyer was Renaissance Technologies, adding an estimated $240K. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $55K sold.

  • 28 institutional investors held Altimmune (ALT) as of Q4 2019, down from 30 in Q3 2019.
  • Funds reported $2.44M of Altimmune stock for Q4 2019, up 12% quarter-over-quarter.
  • 6 funds opened new Altimmune positions in Q4 2019 and 8 closed out, a net change of -2 holders.
  • The largest Altimmune buyer in Q4 2019 was Renaissance Technologies, an estimated $240K added.
  • The largest Altimmune seller in Q4 2019 was A.R.T. Advisors, an estimated $55K sold.

Based on aggregated 13F filings for Q4 2019.